MediBeacon® Transdermal GFR System receives device approval in China

MediBeacon® Transdermal GFR System receives device approval in China

Peer-reviewed articles on MediBeacon technology published Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function. The Clinical Kidney Journal in...

HKBU receives resounding support from Nobel Laureate and field experts in new medical school proposal and the establishment of translational medical research institute

HKBU receives resounding support from Nobel Laureate and field experts in new medical school proposal and the establishment of translational medical research institute

HONG KONG, Feb. 24, 2025 /PRNewswire/ -- The Preparatory Committee and Expert Advisory Committee for the New Medical School set up by Hong Kong Baptist University (HKBU) held a meeting yesterday (23 February), during which progress of the...

Global Education Leader Recognised: Trio Schools' Managing Director receives prestigious BW Education 40 Under 40 award for educational innovation in India

Global Education Leader Recognised: Trio Schools' Managing Director receives prestigious BW Education 40 Under 40 award for educational innovation in India

BENGALURU, India, Feb. 21, 2025 /PRNewswire/ -- Trio Schools' Managing Director, Mr. Naveen KM has been honoured with the prestigious BW Education 40 under 40 award, in association with Business World, for his contributions to the field of...

NAVER D2SF-Backed PranaQ® Receives FDA 510(k) Clearance for TipTraQ, an AI-Enabled Home Sleep Apnea Test

NAVER D2SF-Backed PranaQ® Receives FDA 510(k) Clearance for TipTraQ, an AI-Enabled Home Sleep Apnea Test

SEOUL, South Korea, Feb. 21, 2025 /PRNewswire/ -- PranaQ, backed by NAVER D2SF continues to push the boundaries of AI-powered healthcare solutions. NAVER D2SF, NAVER's corporate venturing arm, actively collaborates with startups to drive innovation...

Clarity receives US FDA Fast Track Designation for the treatment of metastatic castration-resistant prostate cancer patients with Cu-67 SAR-bisPSMA

Clarity receives US FDA Fast Track Designation for the treatment of metastatic castration-resistant prostate cancer patients with Cu-67 SAR-bisPSMA

SYDNEY, Feb. 19, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and...

Innovent Receives Second Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Squamous Non-Small Cell Lung Cancer

Innovent Receives Second Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Squamous Non-Small Cell Lung Cancer

SAN FRANCISCO and SUZHOU, China, Feb. 17, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of...

Navi Medical Technologies' Neonav® ECG Tip Location System Receives FDA 510(k) Clearance

Navi Medical Technologies' Neonav® ECG Tip Location System Receives FDA 510(k) Clearance

Revolutionising Vascular Access Care for Critically Ill Newborns and Children Key Points: FDA 510(k) Clearance Neonav® ECG Tip Location System is now FDA-cleared, enabling its use in U.S. hospitals to enhance pediatric vascular access care....

Mingzhu Receives Nasdaq Delisting Notice Subject to Hearing Request

Mingzhu Receives Nasdaq Delisting Notice Subject to Hearing Request

SHENZHEN, China, Feb. 15, 2025 /PRNewswire/ -- MingZhu Logistics Holdings Limited ("MingZhu" or the "Company") (Nasdaq: YGMZ ), an elite provider of logistics and transportation services to businesses, today announced that on February 13, 2025, it...

Arcadium Lithium Receives All Required Regulatory Approvals Globally to Close Acquisition by Rio Tinto and Announces Court Hearing Date

Arcadium Lithium Receives All Required Regulatory Approvals Globally to Close Acquisition by Rio Tinto and Announces Court Hearing Date

PHILADELPHIA and PERTH, Australia, Feb. 14, 2025 /PRNewswire/ -- Arcadium Lithium plc (NYSE: ALTM, ASX: LTM, "Arcadium Lithium"), a leading global lithium chemicals producer, has now received all required pre-closing regulatory approvals in...

OnCusp Therapeutics Receives FDA Fast Track Designation for CUSP06 for the Treatment of Platinum-Resistant Ovarian Cancer

OnCusp Therapeutics Receives FDA Fast Track Designation for CUSP06 for the Treatment of Platinum-Resistant Ovarian Cancer

PRINCETON, N.J., Feb. 12, 2025 /PRNewswire/ -- OnCusp Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer patients, today...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • menu
    menu